Get started
Author

Hidetaka Arita

Observed names: Arita Hidetaka, Arita, Hidetaka, H Arita, Hidetaka ARITA
ORCID: 0000-0002-8255-2217
Observed ORCID: 0000-0002-8255-2217
OpenAlex ID: A5049670023
IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinoma
2016 · Yuichiro Matsuoka, Hideki Nakayama, et al. · British Journal of Cancer · 130
PDF
Pre-treatment neutrophil to lymphocyte ratio predicts the chemoradiotherapy outcome and survival in patients with oral squamous cell carcinoma: a retrospective study
2016 · Hikaru Nakashima, Yuichiro Matsuoka, et al. · BMC Cancer · 65
PDF
The tumour stromal features are associated with resistance to 5-FU-based chemoradiotherapy and a poor prognosis in patients with oral squamous cell carcinoma
2014 · Yuichiro Matsuoka, Ryoji Yoshida, et al. · Apmis · 56
Naringenin potentiates anti-tumor immunity against oral cancer by inducing lymph node CD169-positive macrophage activation and cytotoxic T cell infiltration
2022 · Sho Kawaguchi, Kenta Kawahara, et al. · Cancer Immunology Immunotherapy · 49
PDF
Extracellular vesicles derived from radioresistant oral squamous cell carcinoma cells contribute to the acquisition of radioresistance via the miR‐503‐3p‐BAK axis
2021 · Keisuke Yamana, Junki Inoue, et al. · Journal of Extracellular Vesicles · 47
PDF
Tumor budding as a novel predictor of occult metastasis in cT2N0 tongue squamous cell carcinoma
2018 · Junki Sakata, Keisuke Yamana, et al. · Human Pathology · 47
The antioxidative stress regulator Nrf2 potentiates radioresistance of oral squamous cell carcinoma accompanied with metabolic modulation
2022 · Yuichiro Matsuoka, Ryoji Yoshida, et al. · Laboratory Investigation · 45
HMGA2 Contributes to Distant Metastasis and Poor Prognosis by Promoting Angiogenesis in Oral Squamous Cell Carcinoma
2019 · Junki Sakata, Akiyuki Hirosue, et al. · International Journal of Molecular Sciences · 44
PDF
Circulating miRNA-1290 as a potential biomarker for response to chemoradiotherapy and prognosis of patients with advanced oral squamous cell carcinoma: A single-center retrospective study
2019 · Hikaru Nakashima, Ryoji Yoshida, et al. · Tumor Biology · 38
Overexpression of nucleostemin contributes to an advanced malignant phenotype and a poor prognosis in oral squamous cell carcinoma
2014 · R Yoshida, H Nakayama, et al. · British Journal of Cancer · 30
PDF
Predictive value of the combination of SMAD4 expression and lymphocyte infiltration in malignant transformation of oral leukoplakia
2017 · Junki Sakata, Ryoji Yoshida, et al. · Cancer Medicine · 20
PDF
Postoperative delirium in patients undergoing tumor resection with reconstructive surgery for oral cancer
2021 · Nozomu Takahashi, Akimitsu Hiraki, et al. · Molecular and Clinical Oncology · 19
PDF
Enhanced Expression of IGFBP-3 Reduces Radiosensitivity and Is Associated with Poor Prognosis in Oral Squamous Cell Carcinoma
2020 · Junki Sakata, Akiyuki Hirosue, et al. · Cancers · 18
PDF
An oncolytic virus as a promising candidate for the treatment of radioresistant oral squamous cell carcinoma
2022 · Shunsuke Gohara, Kosuke Shinohara, et al. · Molecular Therapy — Oncolytics · 14
FOXP3 lymphocyte status may predict the risk of malignant transformation in oral leukoplakia
2019 · Junki Sakata, Ryoji Yoshida, et al. · Journal of Oral and Maxillofacial Surgery Medicine and Pathology · 14
FBXW7 expression affects the response to chemoradiotherapy and overall survival among patients with oral squamous cell carcinoma: A single-center retrospective study
2017 · Hidetaka Arita, Masashi Nagata, et al. · Tumor Biology · 14
Salivary duct carcinoma treated with cetuximab-based targeted therapy: A case report
2017 · Kenta Kawahara, Akimitsu Hiraki, et al. · Molecular and Clinical Oncology · 14
PDF
Role of serum amylase and salivary cytokines in oral complications during chemoradiotherapy
2020 · Kenta Kawahara, Akimitsu Hiraki, et al. · Oral Diseases · 7
Efficacy of adjuvant chemotherapy with S-1 in stage II oral squamous cell carcinoma patients: A comparative study using the propensity score matching method
2020 · Ryoji Yoshida, Masashi Nagata, et al. · PLoS ONE · 5
Three-dimensional volumetric analysis of the efficiency of marsupialization in patients with mandibular dentigerous cysts involving impacted third molars
2022 · Masatoshi Hirayama, Kazushige Inoue, et al. · Journal of Oral and Maxillofacial Surgery Medicine and Pathology · 4
PDF
miR-30a attenuates drug sensitivity to 5-FU by modulating cell proliferation possibly by downregulating cyclin E2 in oral squamous cell carcinoma
2021 · Kenta Kawahara, Masashi Nagata, et al. · Biochemistry and Biophysics Reports · 4
PDF
Extramammary Paget's disease of the hard palate: A case report and review of the literature
2021 · Mari Shimomura, Fumi Kawakami, et al. · Pathology International · 3
Osteopontin derived from tumor-associated macrophages modulates radiosensitivity of oral squamous cell carcinoma via reactive oxygen species production
2025 · Hikaru Nakashima, Keisuke Yamana, et al. · Journal of Oral and Maxillofacial Surgery Medicine and Pathology · 2
Re‑evaluating the clinical significance of serum p53 antibody levels in patients with oral cancer in Japanese clinical practice
2021 · Shunsuke Gohara, Ryoji Yoshida, et al. · Molecular and Clinical Oncology · 2
PDF
Age-related differences in tongue squamous cell carcinoma: Insights from propensity score-matched analyses
2026 · Hibiki Nakamura-Yamada, Yuka Nagao, et al. · Journal of Oral and Maxillofacial Surgery Medicine and Pathology · 1
Works count: 33
Citation count: 692
H-index: 14
I10-index: 17
Year
Topic
Type